CVS Health is rolling out a new customer app that aims to make it simpler and more convenient for users to manage health benefits, pharmacy benefits and prescriptions. | CVS Health is rolling out a new customer app designed to make it simpler and more convenient for users to manage health benefits,

CVS Health (CVS) on Tuesday announced the launch of the CVS Health app. The app, a successor to the CVS Pharmacy app and one of many

In the lawsuit, AG Gentner Drummond outlined 200 individual prescription claims that were reimbursed below acquisition cost to 15 Oklahoma pharmacies.

Attorney General Gentner Drummond sued CVS Caremark in an Oklahoma administrative court alleging that the company is under reimbursing pharmacies for prescription drugs.

Superlong pharmacy lines and locked-up cabinets are among the areas the healthcare company is targeting with a new app, unveiled Tuesday.

If you've ever shopped at CVS and had to wait while an employee shows up to unlock a cabinet so you could get a bottle of detergent, the drug store chain has good news for you.

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without many pharmacy options.

If you've ever been frustrated while shopping at your local pharmacy, you're hardly alone — but now CVS has devised a plan to change that with it's new iPhone app.

CVS Health® (NYSE: CVS) today announced the launch of the CVS Health app. New features of the app will bring together all CVS Health has to offer to consumers, helping make health care more accessible,

The well-known US pharmacy chain CVS is embracing the iPhone in a whole new way, with a redesigned app that aims to help customers get in and out of their stores more quickly and with less frustration.

Attorney General Gentner Drummond sued CVS Caremark Tuesday in an Oklahoma administrative court alleging that the company is under reimbursing pharmacies for prescription drugs. The lawsuit alleges CVS Caremark reimbursed Oklahoma pharmacies below the actual cost to acquire the drugs about 200 times between May and October 2024.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of